Karl A. Thiel is a freelance writer based in Portland, Oregon, USA.
Has a worldwide shortage in biomanufacturing capacity turned to a glut in just 4 years? A building boom and advances in technology threaten to derail adoption of potentially cheaper transgenic manufacturing platforms.